自制银纳米颗粒在难治性转移性头颈部鳞状细胞癌中的活性与药理学
一例78岁男性鼻腔鳞状细胞癌肝肺转移患者,在临终关怀期间按网络说明自制并摄入银纳米颗粒(AgNP)溶液。电镜显示粒径呈3和12 nm双峰分布,摄入60 mL后血银离子浓度由32 ng/g升至46 ng/g(1小时),尿液未检出AgNP,未观察到毒性,影像学肿瘤完全消退,18个月后仍无肿瘤证据。作者认为AgNP摄入与持续的影像学肿瘤消退相关,应进一步检测以确认其疗效。
要点
- 自制AgNP溶液粒径呈3和12 nm双峰分布。
- 摄入60 mL后1小时血银离子浓度由32 ng/g升至46 ng/g。
- 未观察到毒性,影像学肿瘤完全消退,18个月后仍无肿瘤证据。
核心结论
- AgNP摄入与难治性转移性头颈部鳞状细胞癌的持续影像学消退相关。
- 作者认为应进一步检测AgNP以确认其在头颈部癌中的疗效。
研究设计与样本
- 首次在癌症患者中报告AgNP结局的人体病例报告。
- 患者为78岁男性,患鼻腔鳞状细胞癌并转移至肝和肺。
- 患者在临终关怀期间按网络说明自制AgNP溶液并开始摄入。
主要发现
- 电镜显示AgNP溶液粒径呈双峰分布:3和12 nm。
- 电感耦合等离子体质谱显示基础血银离子浓度为32 ng/g,摄入60 mL AgNP溶液后1小时升至46 ng/g。
- 尿液未检出AgNP。
- 未观察到毒性,患者癌症影像学完全消退。
- 18个月后仍无肿瘤证据。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
- 作者在结论中提出应进一步检测AgNP以确认其疗效。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Silver nanoparticles (AgNP) show efficacy in cancer cell lines. We present the first in-human outcome of AgNP in a cancer patient. METHODS: Homemade AgNP solution is manufactured using online instructions by a 78-year old male. He started consuming AgNP while on hospice after he developed nasal cavity squamous cell cancer metastatic to liver and lung. RESULTS: Electron microscopy of AgNP solution revealed bimodal nanoparticle size distribution: 3 and 12 nm. Inductively coupled plasma mass spectrometry showed basal silver ion concentrations of 32 ng/g, rising to 46 ng/g 1 hour after ingesting 60 mL of AgNP solution. Urine showed no AgNP. No toxicities were observed and he had complete radiographic resolution of his cancer. He remains without evidence of cancer 18 months later. CONCLUSIONS: AgNP ingestion was associated with sustained radiographic resolution of cancer. Further testing of AgNP should be done to confirm its efficacy in head and neck cancer.
引用
- Singh J, Moore W, Fattah F, et al. Activity and pharmacology of homemade silver nanoparticles in refractory metastatic head and neck squamous cell cancer. Head Neck. 2018. PMID: 30537286. doi:10.1002/hed.25492
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。